Anti-TNFα in inflammatory bowel disease: from originators to biosimilars

• Asıl Yazarlar: Zhen Zeng (Yazar), Hao Lin (Yazar), Mingshan Jiang (Yazar), Jing Yuan (Yazar), Xi Li (Yazar), Yongbin Jia (Yazar), Li Yang (Yazar), Hu Zhang (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2024-07-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

The introduction of anti-tumor necrosis factor α (TNFα) biologics significantly innovated inflammatory bowel disease (IBD) treatment and increased medical costs. The recent expiration of patents of some anti-TNFα biologics (such as infliximab and adalimumab) facilitated the development of biosimilar...